- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Beam Therapeutics Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Beam Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Beam Therapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Beam Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Beam Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. My name is Gena Wang. I'm SMid-Cap Biotech Analyst at Barclays. Welcome to Barclays Global Healthcare Conference. It is my great pleasure to introduce our next presenting company, Beam Therapeutics. With us, we have Giuseppe Pino Ciaramella, Chief Scientific Officer and President.
Pino, do you want to give a brief overview before we dive into specific questions?
Yes, of course. And thank you very much for the opportunity to come and share some of our updates. Yes, so Beam Therapeutics is a next-generation gene-editing company that uses primarily this technology known as base editing. It is still a Cas9-based technology. But we use Cas9 as the landing pad and the targeting domain. But we have changed in a very important way so it no longer makes the double-stranded break, which we believe leads to some unwanted outcomes in editing.
Instead, fuse to the protease, is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)